First Time Loading...
S

SCHOTT Pharma AG & Co KgaA
XETRA:1SXP

Watchlist Manager
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Watchlist
Price: 31.52 EUR -1.5%
Updated: May 20, 2024

Income Statement

Earnings Waterfall
SCHOTT Pharma AG & Co KgaA

Revenue
1.1B EUR
Cost of Revenue
-730.6m EUR
Gross Profit
400.2m EUR
Operating Expenses
-167.5m EUR
Operating Income
232.7m EUR
Other Expenses
-36.4m EUR
Net Income
196.3m EUR

Income Statement
SCHOTT Pharma AG & Co KgaA

Rotate your device to view
Income Statement
Currency: EUR
Sep-2023 Dec-2023
Revenue
Revenue
899
N/A
1 131
+26%
Gross Profit
Cost of Revenue
(582)
(731)
Gross Profit
316
N/A
400
+26%
Operating Income
Operating Expenses
(145)
(168)
Selling, General & Administrative
(126)
(154)
Research & Development
(27)
(33)
Other Operating Expenses
7
19
Operating Income
171
N/A
233
+36%
Pre-Tax Income
Interest Income Expense
17
11
Non-Reccuring Items
7
4
Total Other Income
(9)
(5)
Pre-Tax Income
186
N/A
241
+30%
Net Income
Tax Provision
(34)
(45)
Income from Continuing Operations
152
196
Income to Minority Interest
(0)
(0)
Net Income (Common)
152
N/A
196
+29%
EPS (Diluted)
1.01
N/A
1.3
+29%

See Also

Discover More